1. Real world outcomes with Bortezomib Thalidomide dexamethasone and Cyclophosphamide Bortezomib dexamethasone induction treatment for transplant eligible multiple myeloma patients in a Latin American country. A Retrospective Cohort Study from Grupo Argentino de Mieloma Múltiple. Issue 3 (20th April 2020) Authors: Schütz, Natalia P.; Ochoa, Paola; Duarte, Patricio; Remaggi, Guillermina; Yantorno, Sebastián; Corzo, Ariel; Zabaljauregui, Soledad; Shanley, Claudia; Lopresti, Sergio; Orlando, Sergio; Verri, Verónica; Quiroga, Luis; García, Carlos A.; Fernández, Vanesa; Fantl, Dorotea Journal: Hematological oncology Issue: Volume 38:Issue 3(2020) Page Start: 363 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗